JOHN MARAGANORE - 06 Jun 2024 Form 3 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Role
Director
Signature
/s/ Cheryl Gault, Attorney-in-Fact
Issuer symbol
RAPP
Transactions as of
06 Jun 2024
Transactions value $
$0
Form type
3
Filing time
06 Jun 2024, 18:56:44 UTC
Previous filing
07 Jun 2024
Next filing
20 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RAPP Stock Option (Right to Buy) 06 Jun 2024 Common Stock 87.6K $9.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest and become exercisable in sixteen (16) equal quarterly installments, with the first installment vesting on April 18, 2024, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney